GL1X · GenesisL1 explorer

MolNFT v1 · #103168 · protein

Structure of ribb complexed with substrate (RU5P) and metal ions

4P8E · 3,4-dihydroxy-2-butanone 4-phosphate synthase: “Structure of ribb complexed with substrate (RU5P) and metal ions”. X-ray diffraction, 2 ligands (5RP, ZN), 2 pockets (best druggability 0.67). MolNFT v1 #103168 on GenesisL1: 3D…

PDB
4P8E
Type
protein
Length
433 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3,4-dihydroxy-2-butanone 4-phosphate synthase
EC
4.1.99.12
UniProt
Q9KKP2
Ligands
5RP, ZN
Pockets
2 · best druggability 0.67

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3,4-dihydroxy-2-butanone 4-phosphate synthase (EC 4.1.99.12)protein21642% helix, 20% strandQ9KKP2
B3,4-dihydroxy-2-butanone 4-phosphate synthase (EC 4.1.99.12)protein21741% helix, 20% strandQ9KKP2

Ligands and binding sites

  • 5RP · Ribulose-5-phosphate · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 10 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 8 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1900.670.92305RP, ZN
2540.350.7916empty

Interfaces

1 interface between chains.

  • A–B · 1557 Ų buried · 16 hydrogen bonds · protein-protein

Compared structures

  • 4P8E · Structure of ribB complexed with substrate (Ru5P) and metal ions · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9KKP2 · AlphaFold monomer V2.0 prediction for 3,4-dihydroxy-2-butanone 4-phosphate synthase… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.